182 related articles for article (PubMed ID: 36274054)
21. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.
Wang M; Zhang Z; Pan D; Xin Z; Bu F; Zhang Y; Tian Q; Feng X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212174
[TBL] [Abstract][Full Text] [Related]
22. Deregulation of long noncoding RNAs ANCR, TINCR, HOTTIP and SPRY4-IT1 in plasma of systemic sclerosis patients: SPRY4-IT1 as a novel biomarker of scleroderma and its subtypes.
Abd-Elmawla MA; Hassan M; Elsabagh YA; Alnaggar ARLR; Senousy MA
Cytokine; 2020 Sep; 133():155124. PubMed ID: 32442909
[TBL] [Abstract][Full Text] [Related]
23. The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1.
Wu H; Wang Y; Chen T; Li Y; Wang H; Zhang L; Chen S; Wang W; Yang Q; Chen C
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30104400
[TBL] [Abstract][Full Text] [Related]
24. Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer.
Tan W; Song ZZ; Xu Q; Qu X; Li Z; Wang Y; Yu Q; Wang S
Med Sci Monit; 2017 Jan; 23():309-314. PubMed ID: 28099409
[TBL] [Abstract][Full Text] [Related]
25. lncRNAs in Non-Malignant Tissue Have Prognostic Value in Colorectal Cancer.
Thiele JA; Hosek P; Kralovcova E; Ostasov P; Liska V; Bruha J; Vycital O; Rosendorf J; Opattova A; Horak J; Kralickova M; Vodicka P; Pitule P
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205577
[TBL] [Abstract][Full Text] [Related]
26. LncRNAs AK058003 and MVIH Overexpression in the Blood Samples of Iranian Breast Cancer Patients.
Akhavan Attar F; Oloomi M; Irani S; Azizi M; Geranpayeh L
Iran Biomed J; 2021 Mar; 25(2):93-8. PubMed ID: 33462225
[TBL] [Abstract][Full Text] [Related]
27. Investigating the diagnostic performance of HOTTIP, PVT1, and UCA1 long noncoding RNAs as a predictive panel for the screening of colorectal cancer patients with lymph node metastasis.
Gharib E; Anaraki F; Baghdar K; Ghavidel P; Sadeghi H; Nasrabadi PN; Peyravian N; Aghdaei HA; Zali MR; Mojarad EN
J Cell Biochem; 2019 Sep; 120(9):14780-14790. PubMed ID: 30993787
[TBL] [Abstract][Full Text] [Related]
28. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
29. CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21 'gene desert', serve as important prognostic biomarkers in colorectal cancer.
Ozawa T; Matsuyama T; Toiyama Y; Takahashi N; Ishikawa T; Uetake H; Yamada Y; Kusunoki M; Calin G; Goel A
Ann Oncol; 2017 Aug; 28(8):1882-1888. PubMed ID: 28838211
[TBL] [Abstract][Full Text] [Related]
30. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
31. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
[TBL] [Abstract][Full Text] [Related]
32. Parkinson's Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAs.
Honarmand Tamizkar K; Gorji P; Gholipour M; Hussen BM; Mazdeh M; Eslami S; Taheri M; Ghafouri-Fard S
Front Immunol; 2021; 12():763323. PubMed ID: 34868009
[TBL] [Abstract][Full Text] [Related]
33. The long non-coding RNA SPRY4-IT1: An emerging player in tumorigenesis and osteosarcoma.
Li Z; Shen J; Chan MTV; Wu WKK
Cell Prolif; 2018 Aug; 51(4):e12446. PubMed ID: 29484753
[TBL] [Abstract][Full Text] [Related]
34. The functional pathway analysis and clinical significance of miR-20a and its related lncRNAs in breast cancer.
Zhao L; Zhao Y; He Y; Li Q; Mao Y
Cell Signal; 2018 Nov; 51():152-165. PubMed ID: 30092355
[TBL] [Abstract][Full Text] [Related]
35. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W
Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271
[TBL] [Abstract][Full Text] [Related]
36. SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers.
Li J; Chen Y; Chen Z; He A; Xie H; Zhang Q; Cai Z; Liu Y; Huang W
Tumour Biol; 2017 Jun; 39(6):1010428317711406. PubMed ID: 28651500
[TBL] [Abstract][Full Text] [Related]
37. Circulating exosomal long non-coding RNA H19 as a potential novel diagnostic and prognostic biomarker for gastric cancer.
Zhou H; Shen W; Zou H; Lv Q; Shao P
J Int Med Res; 2020 Jul; 48(7):300060520934297. PubMed ID: 32660285
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.
Song X; Zhang X; Wang X; Chen L; Jiang L; Zheng A; Zhang M; Zhao L; Wei M
J Cell Mol Med; 2020 Jan; 24(1):772-784. PubMed ID: 31736268
[TBL] [Abstract][Full Text] [Related]
39. Long Non-Coding RNA SPRY4-IT1 Can Predict Poor Prognosis in Digestive System Malignancies: a Meta-Analysis.
Sun C; Ding Y; Wang S; Hu W
Pathol Oncol Res; 2019 Jan; 25(1):89-95. PubMed ID: 28965279
[TBL] [Abstract][Full Text] [Related]
40. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
Li YW; Li L
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]